60 Participants Needed

tDCS + Cognitive Training for Post-Stroke Cognitive Impairment

(TIPSCI Trial)

EB
Overseen ByElisabeth B Marsh, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Johns Hopkins University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if a treatment combining mild brain stimulation and computer-based mental exercises can aid individuals with memory and thinking problems following a minor stroke. Participants will be divided into two groups: one will receive actual brain stimulation using Anodal transcranial Direct Current Stimulation (A-tDCS), while the other will receive a placebo version. Both groups will engage in the mental exercises. Researchers will assess brain activity and cognitive improvement before and after the treatment. Individuals who have experienced a minor stroke in the last month and have mild cognitive issues may be suitable candidates for this study. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance cognitive recovery after a stroke.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this method is safe for post-stroke cognitive impairment?

Research has shown that anodal transcranial Direct Current Stimulation (A-tDCS) is safe and well-tolerated. Studies have found that tDCS is a safe, painless, and non-invasive method used to improve thinking skills in stroke patients. One study examined the safety of A-tDCS when applied to the brain area affected by a stroke and found no harm to the brain's structure or function. This suggests that A-tDCS can be safely used in stroke recovery without causing negative side effects.12345

Why are researchers excited about this trial?

Most treatments for post-stroke cognitive impairment focus on medication and physical rehabilitation. However, the treatment being studied, Anodal transcranial Direct Current Stimulation (A-tDCS), offers a unique approach. A-tDCS uses electrical currents to stimulate the brain's frontoparietal cortex, potentially enhancing the effects of cognitive therapy. Researchers are excited because this method could improve cognitive function by directly targeting brain regions involved in recovery, potentially offering faster and more effective results than traditional therapies.

What evidence suggests that this trial's treatments could be effective for post-stroke cognitive impairment?

Research has shown that anodal transcranial Direct Current Stimulation (A-tDCS), a treatment participants in this trial may receive, can improve thinking and memory in people with cognitive problems after a stroke. This treatment uses a gentle electrical current to stimulate the brain, strengthening brain connections. Studies have found that A-tDCS boosts brain activity and enhances thinking skills. It is considered a safe and practical option for recovery. Some research even suggests it can lead to long-term improvements by enhancing brain connectivity. Overall, A-tDCS offers hope for those facing cognitive challenges after a stroke.12367

Who Is on the Research Team?

EB

Elisabeth B Marsh, MD

Principal Investigator

Johns Hopkins University

Are You a Good Fit for This Trial?

This trial is for adults over 18 who've had a minor stroke within the last week and show mild cognitive issues afterward. They must speak English, have manageable stroke symptoms (NIHSS <8), and be relatively independent (mRS 0-2). People with dementia, severe psychiatric illness, or those unable to attend sessions are excluded.

Inclusion Criteria

Your stroke severity score is less than 8 at your first follow-up visit, which is about 30 days after the stroke.
I am an adult who had stroke symptoms start within the last week.
You have recently had a stroke shown on a brain MRI. Strokes that don't show up on imaging and transient ischemic attacks (TIAs) will also be excluded.
See 2 more

Exclusion Criteria

You have bleeding in your brain as shown by a head CT or MRI.
I have hearing or vision problems that haven't been corrected.
I have a major blood vessel blockage near my heart or brain.
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive 15 sessions of anodal tDCS or sham intervention over 5 weeks, combined with computerized cognitive therapy (CCT)

5 weeks
15 sessions (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with MEG and cognitive assessments at 1, 3, and 6 months post-stroke

6 months
3 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Anodal transcranial Direct Current Stimulation (A-tDCS)
  • Sham Intervention
Trial Overview The study tests if anodal transcranial Direct Current Stimulation (A-tDCS) combined with computerized cognitive treatment improves cognition in post-stroke patients compared to a sham intervention. It's randomized and double-blinded, meaning participants won't know which treatment they're getting.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: A-tDCSExperimental Treatment1 Intervention
Group II: Sham InterventionActive Control1 Intervention

Anodal transcranial Direct Current Stimulation (A-tDCS) is already approved in United States, European Union, China for the following indications:

🇺🇸
Approved in United States as Transcranial Direct Current Stimulation for:
🇪🇺
Approved in European Union as Transcranial Direct Current Stimulation for:
🇨🇳
Approved in China as Transcranial Direct Current Stimulation for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Johns Hopkins University

Lead Sponsor

Trials
2,366
Recruited
15,160,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

University of Maryland, College Park

Collaborator

Trials
163
Recruited
46,800+

Published Research Related to This Trial

In a study involving 39 healthy young adults, repeated sessions of anodal high-definition transcranial direct current stimulation (HD-tDCS) over 4 weeks significantly improved executive control and psychomotor efficiency, with benefits increasing over time.
Unlike the sham group, which showed a return to baseline performance after 9 sessions, the anodal group maintained their improvements in attention, suggesting that repeated HD-tDCS has a cumulative positive effect on cognitive function.
Modulation of Repeated Anodal HD-tDCS on Attention in Healthy Young Adults.Lu, H., Liu, Q., Guo, Z., et al.[2020]
Transcranial direct current stimulation (tDCS) is a safe and affordable neuromodulatory technique that shows potential for modulating cognitive functioning, particularly in longitudinal studies where repeated sessions are used.
While tDCS has demonstrated some cognitive benefits, the effects are less consistent compared to its impact on motor outcomes, and more research is needed to understand the mechanisms behind its efficacy and to identify which individuals respond best to the treatment.
Cognitive Effects of Transcranial Direct Current Stimulation in Healthy and Clinical Populations: An Overview.Berryhill, ME., Martin, D.[2019]
In a study involving 11 newly diagnosed stroke patients, the combination of transcranial direct current stimulation (tDCS) and computer-assisted cognitive rehabilitation (CACR) significantly improved cognitive function compared to a control group receiving sham stimulation.
Patients receiving tDCS showed notable enhancements in auditory and visual continuous performance tests, suggesting that targeting the prefrontal cortex with tDCS alongside cognitive training can effectively aid recovery from cognitive dysfunction after a stroke.
A double-blind, sham-controlled, pilot study to assess the effects of the concomitant use of transcranial direct current stimulation with the computer assisted cognitive rehabilitation to the prefrontal cortex on cognitive functions in patients with stroke.Park, SH., Koh, EJ., Choi, HY., et al.[2022]

Citations

Transcranial Direct Current Stimulation to Ameliorate Post ...In this review, we describe a promising intervention, transcranial direct current stimulation (tDCS), to treat post-stroke cognitive impairment by leveraging ...
Home-Based Transcranial Direct Current Stimulation to ...Conclusions: RS-tDCS is a safe and feasible rehabilitation modality for poststroke cognitive dysfunction. Specifically, RS-tDCS is effective in ...
Transcranial Direct Current Stimulation for Cognitive ...This study presents the first bibliometric analysis of the literature on tDCS in the rehabilitation of cognitive impairment, highlighting key areas of research ...
efficacy and mechanisms of dual-target anodal tDCS in ...Although transcranial direct current stimulation (tDCS) has emerged as a promising non-invasive neuromodulation technique to improve cognitive function, ...
TDCS to Improve Post-Stroke Cognitive ImpairmentNeural modulation with transcranial direct current stimulation (tDCS) increases the likelihood of neural firing, strengthening connectivity by promoting long- ...
Safety of ipsilesional anodal transcranial direct current ...In this present study, we aimed to evaluate structural and behavioral safety of anodal tDCS applied in the acute phase of stroke.
The Effects of Transcranial Direct-Current Stimulation on ...The results from this study confirmed that applying tDCS to the left temporal lobe effectively improved auditory memory of patients with poststroke cognitive ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security